Off United States, the COVID-19 vaccine vaccine was temporarily removed from the Baltimore plant by the Emergent BioSolutions company, while the production of 15 million Johnson & Johnson (J&J) vaccine was lost and lost. that the pharmaceutical company AstraZeneca uses the facilities to manufacture its vacuum.
Hace unas semanas, reports The New York Times: the fact that the Baltimores of Emergent BioSolutions are the instalaciones of the Emergent BioSolutions is specialization and the desarrollo of the holidays and therapies of anticuerpos, the ingredient of the vacancies of J&J and AstraZeneca. However, the company stated that “it will assume all responsibility” for the installations. Agreed with J&J, the lot that was stripped did not pass the reading and marketing phase.
In response, the Department of Health and Human Services announced that this Emergent BioSolutions plant is exclusive to J&J in order to avoid making a similar mistake and to help AstraZeneca find a new plant before it can manufacture its dose. The result is that the Food and Drug Administration of the United States (FDA, by its seal in English) does not have to authorize the English pharmaceuticals to distribute its vaccine to its population.
Agreed with the diary, the confusion is primarily due to the active principle of the vacancies of J&J and AstraZeneca are quite similar. If an ineffective version of the virus, known as Vector, is used, it transmits to the cells to produce a protein that is estimated in the immunological system with which it produces antidepressants for COVID-19. However, the vectors of the vacancies are biologically different and cannot be exchanged.
According to Johnson & Johnson, in its communication it was stated that it would promise to burn 100 million doses in the United States, while the mayor took care of the production of the new vacancies. In addition, the North American nation has an agreement with Canada and Mexico to send around 4 million doses of AstraZeneca, which are manufactured in the United States.
What did you notice?